Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Aldape

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Archives of Neurology|July 16, 2008
Molecular predictors in glioblastoma: toward personalized therapyHoward Colman, Ken Aldape
Brain Pathology (Zurich, Switzerland)|December 7, 2010
The use of global profiling in biomarker development for gliomasErik P Sulman, Ken Aldape
Current Problems in Cancer|May 27, 2008
Brain tumor stem cellsErik Sulman, Ken Aldape, Howard Colman
Seminars in Radiation Oncology|May 26, 2009
Beyond grade: molecular pathology of malignant gliomasErik P Sulman, Marisol Guerrero, Ken Aldape
Current Problems in Cancer|May 27, 2008
Prognostic and predictive markers in glioma and other neuroepithelial tumorsAndreana L Rivera, Christopher E Pelloski, Erik Sulman, et al.
Journal of Neuro-Oncology|August 6, 2002
Hemorrhage and VEGF expression in a case of primary CNS lymphomaJames Rubenstein, Nancy Fischbein, Ken Aldape, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Twenty-year survival in glioblastoma: a case report and molecular profileChristina Maria Sperduto, Arnab Chakravarti, Ken Aldape, et al.
BMC Complementary and Alternative Medicine|April 23, 2004
In vitro test of external QigongGarret Yount, Jerry Solfvin, Dan Moore, et al.
Neuro-Oncology|March 25, 2017
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsMartin J van den Bent, Michael Weller, Patrick Y Wen, et al.
Journal of Neuro-Oncology|June 9, 2016
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastomaJacob J Mandel, David Cachia, Diane Liu, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Archives of Neurology|July 16, 2008
Molecular predictors in glioblastoma: toward personalized therapyHoward Colman, Ken Aldape
Brain Pathology (Zurich, Switzerland)|December 7, 2010
The use of global profiling in biomarker development for gliomasErik P Sulman, Ken Aldape
Current Problems in Cancer|May 27, 2008
Brain tumor stem cellsErik Sulman, Ken Aldape, Howard Colman
Seminars in Radiation Oncology|May 26, 2009
Beyond grade: molecular pathology of malignant gliomasErik P Sulman, Marisol Guerrero, Ken Aldape
Current Problems in Cancer|May 27, 2008
Prognostic and predictive markers in glioma and other neuroepithelial tumorsAndreana L Rivera, Christopher E Pelloski, Erik Sulman, et al.
Journal of Neuro-Oncology|August 6, 2002
Hemorrhage and VEGF expression in a case of primary CNS lymphomaJames Rubenstein, Nancy Fischbein, Ken Aldape, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Twenty-year survival in glioblastoma: a case report and molecular profileChristina Maria Sperduto, Arnab Chakravarti, Ken Aldape, et al.
BMC Complementary and Alternative Medicine|April 23, 2004
In vitro test of external QigongGarret Yount, Jerry Solfvin, Dan Moore, et al.
Neuro-Oncology|March 25, 2017
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsMartin J van den Bent, Michael Weller, Patrick Y Wen, et al.
Journal of Neuro-Oncology|June 9, 2016
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastomaJacob J Mandel, David Cachia, Diane Liu, et al.
Pageof 6